Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
Junhyung Kim, Seon Jin Yoon, Ju Hyung Moon, Cheol Ryong Ku, Se Hoon Kim, Eun Jig Lee, Sun Ho Kim, Eui Hyun Kim
J Korean Neurosurg Soc. 2019;62(1):114-122. Published online 2018 Dec 31 DOI: https://doi.org/10.3340/jkns.2018.0027
Citations to this article as recorded by 
Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis
Roxana-Ioana Dumitriu-Stan, Iulia-Florentina Burcea, Ramona Dobre, Valeria Nicoleta Nastase, Raluca Amalia Ceausu, Marius Raica, Catalina Poiana
Diagnostics.2024; 14(2): 170. CrossRef
Caratteristiche cliniche, storia clinica a lungo termine e rischio di recidiva degli adenomi ipofisari corticotropi silenti
Giacomo Voltan, Filippo Ceccato
L'Endocrinologo.2023; 24(1): 107. CrossRef
Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery—a retrospective, single-center study
Piotr Sumislawski, Torge Huckhagel, Kara Leigh Krajewski, Jens Aberle, Wolfgang Saeger, Jörg Flitsch, Roman Rotermund
Scientific Reports.2023;[Epub] CrossRef
Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality
Eui Hyun Kim, Junhyung Kim, Cheol Ryong Ku, Eun Jig Lee, Sun Ho Kim
Yonsei Medical Journal.2023; 64(8): 489. CrossRef
Corticotropinomas silentes: experiencia de cinco casos
Guillermo Serra Soler, Carlos Antich Barceló, Antonio Mas Bonet, Ester Antón Valentí, Honorato García Fernández
Medicina Clínica.2021; 156(11): 582. CrossRef
Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases
Keyi Zhang, Xuefei Shou, Hong Chen, Nidan Qiao, Wenqiang He, Zhengyuan Chen, Ming Shen, Shiqi Li, Yao Zhao, Zhaoyun Zhang, Yiming Li, Hongying Ye, Yongfei Wang
Frontiers in Endocrinology.2021;[Epub] CrossRef
Delayed Hyponatremia after Transsphenoidal Surgery for Pituitary Adenomas: A Single Institutional Experience
Yun Gi Hong, Sun Ho Kim, Eui Hyun Kim
Brain Tumor Research and Treatment.2021; 9(1): 16. CrossRef
Silent corticotroph adenomas: Experience with five cases
Guillermo Serra Soler, Carlos Antich Barceló, Antonio Mas Bonet, Ester Antón Valentí, Honorato García Fernández
Medicina Clínica (English Edition).2021; 156(11): 582. CrossRef
A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors
Abhijit Goyal-Honavar, Sauradeep Sarkar, H. S. Asha, Nitin Kapoor, Rajesh Balakrishnan, Harshad Vanjare, Geeta Chacko, Ari G. Chacko
Acta Neurochirurgica.2021; 163(11): 3143. CrossRef
Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience
Seung Woo Hong, Se Hoon Kim, Seung Hoon Lim, Eun Jig Lee, Sun Ho Kim, Cheol Ryong Ku, Eui Hyun Kim
Frontiers in Oncology.2021;[Epub] CrossRef
An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management
Shenzhong Jiang, Xiaokun Chen, Yinzi Wu, Renzhi Wang, Xinjie Bao
Cancers.2021; 13(23): 6134. CrossRef
Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence
Ben A. Strickland, Shane Shahrestani, Robert G. Briggs, Anna Jackanich, Sherwin Tavakol, Kyle Hurth, Mark S. Shiroishi, Chia-Shang J. Liu, John D. Carmichael, Martin Weiss, Gabriel Zada
Journal of Neurosurgery.2021; 135(6): 1706. CrossRef